Dana-Farber Cancer Institute Harvard Medical School
Boston, Massachusetts 02115, USA
. Donald_Kufe@dfci.harvard.edu
Fusions of dendritic cells and renal carcinoma cells have been used
as a vaccine in the effective and non-toxic treatment of patients with metastatic
renal cancer. This approach may be applicable to other tumor types (pages
332−336).
